Amsilk Gmbh

Amsik Gmbh

Basf Se Corporation

Daniel Huemmerich

Thomas Scheibel

Andreas Bausch

Christian Ackerschott

Burghard Liebmann

Kevin Hermanson

Heiko Barg

Heike Brueser

Hubertus Peter Bell

Uri Gat

Sebastian Remmensee

Christian Freudiger

Marcus Fehr

Arne Ptock

Sebastian Rammensee

The present invention is directed to a method of producing nano- and microcapsules from spider silk proteins The invention is further directed to nano- or microcapsules obtainable by this method as well as pharmaceutical, cosmetical and food compositions containing same.

Method of producing nano- and microcapsules of spider silk protein

The present invention is directed to a device and method of controlling the phase separation of one or a mixture of two or more spider silk proteins, leading to the defined and controllable assembly of the said silk protein(s) to defined morphologies, such as spheres, nano fibrils, threads, etc.

Microfluidic device for controlled aggregation of spider silk

Methods of producing nano-and microcapsules of spider silk proteins

The present invention is directed to proteins of natural origin and materials made therefrom, in particular to threads, fibers, foams and gels derived therefrom. The invention further provides the use of these proteins/threads and materials in the field of technology, biotechnology and/or medicine, in particular in the manufacture of wound closure or coverage systems, suture materials and in the manufacture of replacement materials, preferably artificial cartilage or tendon materials, as well as in other commercial applications.

Proteins of natural origin and materials made therefrom

The present invention is directed to recombinant spider silk proteins, nucleic acids, coding for these recombinant spider silk proteins, as well as hosts suitable for expressing those nucleic acids. Furthermore, the present invention is directed to a method of aggregation of spider silk proteins and the use of the proteins in the field of biotechnology and/or medicine and other industrial fields, in particular in the manufacture of automotive parts, in the aircraft construction, in the processing of textiles and leather, as well as in the manufacture and processing of paper and the like.

Recombinant spider silk proteins

The present invention is directed to a method of producing spider dragline and/or flagelliform proteins. The invention is further directed to a method of producing spider threads and to a dragline/flagelliform protein or dragline/flagelliform protein thread produced by these methods. The invention further provides the use of these proteins/threads in the field of biotechnology and/or medicine, in particular in the manufacture of wound closure or coverage systems, suture materials and in the manufacture of replacement materials, preferably artificial cartilage or tendon materials.

Synthesis of spider dragline and/or flagelliform proteins

The present invention relates to a thread preparation process from silk proteins including an apparatus which is appropriate for performing the method. Furthermore, the invention is directed to the threads obtained therewith as well as the use thereof. The invention uses a diffusion unit leading to the production of high-quality silk threads with high yield.

Method and device for producing a thread from silk proteins

Growing community of inventors

Mannheim, Germany

Daniel Huemmerich